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Abstract 
The design and operation of biosensors is not trivial. For instance, variation in the output signal during monitoring of analytes 
cannot usually be controlled. Hence, if such control were possible, and could be triggered on demand, it would greatly 
facilitate system design and operation. Herein, we report the design of two types of voltamperometric immunosensors, in 
which the magnitude of the current output signal (differential pulse voltammetry [DPV]) can be increased or decreased as 
needed. The designed systems use monoclonal and polyclonal anti-human IgG antibodies, conjugated to monopodal 
ferrocene-modified gold nanoparticles that are casted onto screen-printed carbon electrodes (Ab/mFcL/AuNPs/SPCEs). 
Upon addition of human IgG as antigen, the systems exhibit opposite responses according to the Ab: the current decreases 
when monoclonal Ab is used, whereas it increases when polyclonal Ab is used. We attributed the former response to 
inhibition of electron transfer (due to the formation of a protein layer), and the latter response, to a global increase in electron 
transfer (induced by the aggregation of gold nanoparticles). These effects were confirmed by studying a custom-made lipoic 
acid-based bipodal ligand, which confirmed that the increase in current is effectively induced by the aggregation of the 
modified nanoparticles (pAb/mFcL/AuNPs). Both sensors have large dynamic ranges, although the pAb-based one was 
found to be 3.3-times more sensitive. Tests of selectivity and specificity for ovalbumin, -lactalbumin and serum bovine 
albumin showed that the immunosensors are highly selective and specific, even in the presence of up to 1000-fold levels of 
potentially competitive proteins. The limit of detection (LoD) for human IgG using the pAb/mFcL/AuNP bioconjugate was 
estimated to be 0.85 ng/mL. 
Keywords: Signal Control, Voltamperometric Biosensing, Immunosensor, Ferrocene, Gold Nanoparticles.  
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1. Introduction 
Electrochemical biosensors are attracting major 
interest because of their potential for a myriad 
theranostics and environmental applications [1-3]. 
Moreover, they are good candidates for the basis of 
portable point-of-care devices, due to their inherent 
sensitivity, specificity, usability, miniaturisation and 
cost-effectiveness [4-6]. Gold nanoparticles (AuNPs) 
have been extensively used [7-10] in such sensors, 
owing to the fact that their surface Plasmon Resonance 
(SPR) electron field fully encompasses biomolecular 
interactions at nanoscale concentrations to ensure 
highly sensitive bioassays [11-13]. Size is another 
important factor for nanoparticles in electrochemical 
biosensors. For example, in a recent study, 
nanoparticles in the size range of 15 to 30 nm (similar 
to that of biomacromolecules) were recently shown to 
give the improved electrochemical results compared 
with other particles sizes [14-15]. 
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 Electroactive compounds, which are typically used 
as labels/transducers, can convert a biomolecular 
recognition event into measurable electrical signals. 
The amenability of ferrocene derivatives to this task 
has been demonstrated; in fact, they are quite useful 
for amperometric biosensors [16-17]. For instance, 
researchers have built an amperometric glucose sensor 
based on AuNPs modified with a thio-β-
cyclodextrin/ferrocene inclusion complex and 
subsequently conjugated to glucose oxidase. This 
complex transducing system provides efficient 
electron shuttling, thereby enabling the oxidation of 
glucose at low potentials [18]. Very recently, 
ferrocene-functionalised peptide nanowires (size: ca. 
100 nm), coated with poly(diallyl-
dimethylammonium chloride) and subsequently 
conjugated with gold nanoparticles and antibody, 
were used in a sensitive electrochemical 
immunosensor for an ELISA-like human IgG assay 
[19]. Upon addition of the analyte, the intensity of the 
current increase. Another amperometric 
immunosensor for the sensing of tumour necrosis 
factor  (TF), in which the current intensity drops 
upon formation of the sandwich immunoassay, was 
prepared from a hydrogel made of ferrocene-
functionalised phenylalanine [20]. The authors 
attributed the decrease in current to the reduction of 
ferrocene by the ascorbic acid group attached to the 
second antibody of the immunosandwich. In another 
example, a system comprising ferrocene-branched 
chitosan deposited onto a glassy carbon electrode 
subsequently modified with AuNPs and hepatitis B 
surface (hBs) antibody has been used to detect hBs 
antigen (Ag) [21]. Gradual addition of hBs antigen 
induced a decrease in the DPV current, which was 
proportional to the amount of Ag added. The decrease 
in current was attributed to the hindrance of electron 
transfer from the ferrocene mediator to the electrode 
surface upon formation of the antibody–antigen 
immune complex. At higher concentrations of antigen, 
the immunocomplex acts as an inert kinetic barrier to 
electron transfer [22]. 
 The aforementioned amperometric biosensors all 
demonstrate either of two responses: the detection 
leads to either an increase or a decrease in current. 
However, control over the response signal occurring 
in the device has not yet been achieved. Moreover, 
minor changes to the ferrocene compound can 
radically alter the sensor’s electrochemical behaviour 
(i.e. potential-shifting vs. amperometric) of the 
biosensor, as recently reported by Mars et al. [23]. 
 In this paper, we report a controllable design of two 
new electrochemical immunosensors for detection of 
human IgG as model analyte. Both sensors use gold 
nanoparticles modified with a monopodal ferrocene 
ligand (mFcL/AuNPs) and biofunctionalized to either 
monoclonal antibodies (mAb/mFcL/AuNPs) or to 
polyclonal antibodies (pAb/mFcL/AuNPs). We 
showed that in both sensors the antigen binding leads 
to a change in the ferrocene oxidation current. 
However, and quite surprisingly, CV and DPV studies 
indicated that in the mAb-based sensor, the current 
decreases, whereas in the pAb-based sensor, it 
increases (Fig. 1). Further investigations proved that 
the latter response stems from aggregation of the NPs. 
The two biosensors have similar features, although the 
pAb-based one was more sensitive. The selectivity 
and specificity of the biosensors against other proteins 
were also evaluated.  
Fig. 1. Illustration of the responses observed for mAb- or pAb-
functionalised AuNPs using the same antigen human IgG and 
electrochemical immunosensor format human IgG.  
2. Experimental 
2.1. Materials and Apparatuses  
The following chemical and biochemical reagents 
were purchased from Sigma-Aldrich (Germany), and 
used as received without further purification: -lipoic 
acid (≥ 98%); 1-ferrocenylmethanol (97%); 
dimethylaminopyridine (DMAP) (99%); 
HAuCl4·3H2O (99.9%); dicyclohexylcarbimide 
(DCC) (99%); sodium citrate trihydrate (99.0%); 
terephthalaldehyde (99%); sodium borohydride (≥ 
98%); human IgG (hIgG, ≥95% from human serum); 
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anti-human IgG monoclonal (αhIgG produced in 
mouse) or polyclonal (produced in goat) antibodies; 
-lactalbumin (≥ 95% from human milk); ovalbumin 
(≥ 98%); bovine serum albumin (98%); silica gel (60 
mesh) and F254nm fluorescent silica-coated aluminium 
TLC plates. All the solvents used are analytical grade 
and were purchased from LabScan. The gold 
nanoparticles were synthesised by a modified 
Turkevich method (reduction of HAuCl4 with sodium 
citrate) [25]. 
 All voltammetric experiments were performed in 
phosphate buffer solution (PBS, pH = 7.4) using PC-
controlled Metrohm Autolab PGSTAT101 or 
µAutolab III electrochemical workstations. The 
experiments were designed and the data were 
collected using Nova software 1.10. Screen-printed 
carbon electrodes (SPCEs), printed on PET polymer 
foils using a DEK-248 screen printer (DEK 
International), were used for all the electrochemical 
experiments. The SPCEs comprised a 3-mm disk-
shaped carbon working electrode, a printed Ag/AgCl 
reference electrode and a carbon counter electrode and 
were printed on. 
 TEM micrographs were recorded using a Hitachi 
H600 transmission electron microscope. UV-visible 
spectroscopy was obtained on a SPECTRA ax M2e or 
a UNICO SpectroQuest 2800 spectrophotometer. The 
AuNP/antibody bioconjugates were purified on a 
ScanSpeed 1730R thermostatic centrifuge (LoboGene 
A/S, Danemark). All solutions were prepared in 
deionized water generated by a Milli-Q system (>18.2 
MΩ.cm−1) from Millipore Inc. NMR spectra were 
recorded in a Bruker Advance 300 apparatus, in 
CDCl3 at 300 MHz frequency. Chemical shifts are 
reported in ppm relative to tetramethylsilane (TMS) as 
internal reference. 
3. Results and Discussion 
Fig. 2. (a) The DMAP-catalysed synthesis of mFcL, used to functionalise the AuNPs; (b) CV curves of (i: black) mFcL alone; (ii: 
blue) mFcL/AuNPs; and (iii) Ab/mFcL/AuNPs; sweep rate: 50 mV/s; working electrode: 3-mm carbon-printed disk, reference 
electrode: printed AgCl/Ag; (c) Plot of the oxidation and reduction peak currents vs. the square root of the scan rate (inset: plot of 
log ipa vs. logarithm of scan rate), and (d) Schematic of the fabrication of the Ab/mFcL/AuNP-based immunosensor: (i) 
functionalization of the AuNPs with mFcL; (ii) conjugation with mAb or pAb, and surface blocking with BSA; (iii) casting onto 
SPCEs; and (iv) sensing of human IgG antigen. 
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3.1. Design of the immunosensors 
The AuNPs were first functionalised with mFcL, 
which contains a 1,2-dithiolane moiety that has 
excellent affinity for gold [26]. The mFcL ligand was 
prepared via a Steglich DMAP-catalysed 
esterification of thioctic acid and ferrocenylmethanol, 
using DCC as condensing agent (Fig. 2a) [27]. The 
AuNPs were functionalized as described in Fig. 2a. 
The reaction with mFcL did not induce any colour 
change, whereas reaction with a similar but bipodal 
ligand induced a deep purple colouration, as 
previously reported [23]. Moreover UV-visible 
spectroscopy did not indicate any noticeable shift of 
the gold nanoparticle SPR band. The functionalization 
of AuNPs was confirmed by CV measurements of the 
mFcL before and after the addition of the AuNPs [23]. 
Upon addition, the shape and the current intensities of 
the mFcL changed slightly (Fig. 2b). A decrease in the 
peak-to-peak separation (i.e. from ~280 to ~70 mV), 
and an increase in the oxidation peak and reduction 
peak currents, were observed, all suggesting improved 
system reversibility, and a better rate of electron 
transfer to the SPCE electrode, due to the AuNPs [18, 
28-29]. The current increased by 2.2 times (Fig. S1† 
in the Electronic Supplementary Information (ESI) 
file). Finally, to prepare the immunosensors for 
immediate use, the mAb/mFcL/AuNP and 
pAb/mFcL/AuNP bioconjugates were separately 
casted onto the working-electrode area of the SPCE. 
The different steps of the biosensor preparation are 
outlined in Fig. 2d.  
 The modification of mFcL/AuNPs with the 
antibodies and 3% of BSA solution induced a slight 
anodic shift (ca. 20 mV) of the ferrocene E½ potential. 
The plot of the peak currents, recorded between 50 and 
500 mV of the square root of the scan rate, showed 
that the system is still reversible (Fig. 2c). Moreover, 
plotting the logarithm of peak current versus the 
logarithm of scan rate also showed straight lines with 
slopes of 0.50 (R2 > 0.999) for mAb, (inset in Fig. 2c). 
These facts suggest a predominantly diffusion-
controlled mass transfer of the modified gold particles 
from solution to the electrode inner diffusion layer 
[29-31]. 
3.2. Immunosensing of human IgG 
3.2.1. The mAb-based immunosensor 
We first studied the mAb-based immunosensor. 
Successive additions of human IgG (4.7 ng/mL) 
induced a decrease in the DPV current (the ferrocene 
oxidation peak; see inset in Fig. 3b); when higher 
concentrations of human IgG (47 ng/mL) were used, 
the decreases in current were even larger. We 
attributed this effect to recognition of the human IgG 
by the mAb (see Figs. 3a and 3b, and the CVs in Fig. 
S2a). The DPV studies showed a continuous variation 
of the current up to a human IgG concentration of 600 
ng/mL, proving that the immunosensor has a wide 
dynamic range. The calibration graph for the titration 
using CV is showed in Fig. S2b of the ESI file.  
 According to Qui et al. [22] and Ruther et al. [32], 
the decrease in current can be attributed to recognition 
of the antigen by the antibody-modified AuNPs, 
which results in formation of a dense protein layer. 
This layer hinders the completely inhibiting electron 
transfer from the ferrocene centre to the SPCE surface 
and consequently, causing a gradual decrease in the 
current that is proportional to the amount of Ag added. 
 The mAb/mFcL/AuNP was then analysed in the 
presence of high and low amounts of hIgG, by UV-
visible spectroscopy and transmission electron 
microscopy. As expected, due to the nature of the 
monoclonal antibody, no shifts in the UV-visible 
absorbance spectra were observed. The TEM images 
confirmed the mono-dispersity of the AuNPs 
solutions (Fig. S2). 
3.2.2. The pAb-based immunosensor 
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Fig. 3. Variations in DPV current in the mAb-based 
immunosensor, evidencing: (a) antigen/mAb recognition after 
progressive addition of the analytes; (b) decrease in current vs. 
IgG amount, and fitting curves (inset: effect of small antigen 
concentrations on the sensor response); (c) antigen/pAb 
recognition after progressive addition of the analytes; and 
(d) increase in current vs. human IgG amount, and fitting 
curves (inset: effect of small antigen concentrations on the 
sensor response). 
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Interestingly, gradual addition of human IgG to the 
pAb-based sensors led to proportional increases in 
DPV current (Fig. 3c): the current continued to rise 
linearly up to an human IgG concentration of ca. 700 
ng/mL (Fig. 3d). In this case, the increase in current of 
the ferrocene oxidation peak can be reasonably 
attributed to the immune response (recognition of the 
antigen by the pAb). Similar results have been 
obtained by CV titration, CVs and the corresponding 
calibration plot are shown in Fig. S3.  
 We speculated that the aforementioned increase in 
current was due to the aggregation of individual 
pAb/mFcL/AuNP particulates when they are in the 
presence of the antigen. This is a reasonable 
explanation, given that the pAbs should recognize 
different epitopes of the antigen. We also speculated 
that the aggregation improved the deposition of the 
electroactive complexes onto the surface of the 
working electrode. Hence, the individual 
pAb/mFcL/AuNPs would contribute to the increase in 
the current generated from the ferrocene oxidation, 
leading to improved electrochemical response [33]. In 
this scenario, the current will continue to rise until no 
free modified-AuNPs are available (i.e. all AuNPs are 
bound to antigen). 
 To verify our hypotheses, we first studied the 
aggregation of the pAb/mFcL/AuNPs by UV-visible 
spectroscopy. The UV-visible spectra showed that in 
the presence of low levels of antigen (~47 ng/mL), the 
SPR band barely changed, whereas at high levels of 
antigen (~517 ng/mL), it underwent a redshift of ca. 
20 nm (Fig. 4a). Furthermore, unlike the mAb-based 
biosensor, in which the colouration of gold particles 
remained the same at all antigen concentrations (see 
Fig. 4b, inset), in the pAb-based biosensor, the colour 
of the particles changes from reddish to purple 
denoting the aggregation of the gold nanoparticles. 
Figure 4b shows 96-well UV plates in which the 
antigen had been gradually and equally added to mAb 
and pAb solutions. For the pAb experiment, the 
resulting colour change was observable by the naked 
eye whereas no colour change was observed for the 
other Ab [34-37].  
 Using TEM, we then acquired further evidences to 
support our hypotheses. The TEM micrographs 
revealed that in the mAb-based sensor, in presence of 
high loading of the antigen, the particles had remained 
monodisperse (see Fig. 4d), whereas in the pAb-based 
sensor, the particles had indeed aggregated to form 
dense clusters of nanoparticles (see Fig. 4c). Results 
of TEM and UV-visible for mAb-based biosensor are 
given Fig. S4. 
3.2.3. Provoking nanoparticle aggregation to induce 
an increase in current 
Fig. 4. (a) Shifts in the SPR band in the UV-visible spectra 
during recognition of the antigen by the pAb; (b) Visible colour 
change of the pAb/mFcL/AuNP conjugates upon gradual 
addition of human IgG (top), and unchanged colouration of the 
mAb/mFcL/AuNP suspension in the presence of antigen at 
various concentrations conjugate (bottom); (c) and (d) TEM 
micrograph revealing that the pAb/mFcL/AuNPs had aggregated 
at high concentrations of antigen (d), whereas the 
mAb/mFcL/AuNPs had remained monodisperse (c).  
Fig. 5. a) Synthetic route to the lipoic acid-based bipodal ligand; 
b) Schematic of the aggregation of AuNPs containing the 
bipodal ligand; c) UV-Vis spectra for the reddish monodisperse 
mFcL/AuNPs (red plot), and the purple aggregates of 
mFcL/AuNPs containing the bipodal ligand (blue plot) (inset: 
photos of each); and d) Plots of the DPV current for the reddish 
monodisperse mFcL/AuNPs (red plot), and the purple 
aggregates of mFcL/AuNPs containing the bipodal ligand (blue 
plot) 
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In order to prove that the increase in current that we 
observed in the pAb-based immunosensor was due to 
aggregation of the pAb/mFcL/AuNPs triggered by 
recognition of the antigen by the pAbs, we studied an 
artificial organic linker that causes AuNPs to 
aggregate (i.e. that would cause an increase in DPV 
current). We designed and prepared a bipodal lipoic 
acid-based ligand bearing a lipoic unit on each side. 
We chose lipoic acid to avoid ligand exchange at the 
gold surface. The synthesis of the bipodal ligand is 
outlined in Figure 5a. As depicted in Figure 5b, the 
ligand caused the AuNPs to aggregate, which led to 
interaction between their individual SPR bands and 
consequently, to plasmonic coupling. As a result, 
unlike the reddish mFcL/AuNPs, the mFcL/AuNPs 
containing the bipodal ligand were purple, exhibiting 
a 10-nm redshift in their UV-Vis spectrum relative to 
that of the former (Figure 5c) [34-37]. Moreover, when 
1 µL of a conc. ethanolic solution of the bipodal ligand 
was added to 50 µL of mFcL/AuNPs, the particles 
aggregated, provoking an approximately 3-fold 
increase in the DPV current under the same conditions 
previously used (Figure 5d). We can speculated that 
electron transfer from a ferrocene moiety, sandwiched 
between aggregated nanoparticles, to the electrode 
surface is improved by proximity of the former to 
multiple gold nanoparticles. Furthermore, said 
improvement could be attributed to the plasmonic 
coupling, although we did not observe any effect on 
the ferrocene oxidation potential.  
3.2.4. Monoclonal vs. polyclonal 
We run each experiment with anti-human IgG in 
triplicate. The correlation curve for both antibodies are 
straight lines (coefficient of correlation r2 > 0.996), 
which confirmed good reproducibility of the 
measurements [38].  
 Based on the calibration plots, the mAb-based 
immunosensor exhibited a dynamic range of 4.7 to 
~600 ng/mL, a sensitivity of 0.66 10-3 µA·mL/ng and 
a limit of detection (LoD) of 1.75 ng/mL. In contrast, 
the pAb-based immunosensor showed slightly better 
performance, with a dynamic range of 4.7 to 650 
ng/mL, a sensitivity of 2.28 10-3 µA·mL/ng; and an 
LoD of 0.87 ng/mL. Furthermore, it showed a LoQ of 
2.9 ng/mL. 
 Comparing the slopes of the two biosensors, the 
pAb-based immunosensor appears to be ~3.5-fold 
more sensitive. Moreover, it shows a chromogenic 
response and cheaper antibodies. This result sharply 
contrasts with earlier findings from our group (we 
previously reported that a pAb-based, potential-
shifting biosensor was less sensitive than its 
monoclonal analogue [23]) and others [31]. 
3.3. Selectivity and specificity of the immunoassay  
We then sought to assess the selectivity and specificity 
of the pAb-based immunosensor, as these are two 
important features for any biosensor. Several tests 
were run to prove that the observed DPV 
amperometric response was indeed due to formation 
of the immune complex and to rule out the possibility 
that the variations in current were due to non-specific 
protein adsorption on the surface of the AuNPs. BSA, 
α-LA and OVA were separately tested as potentially 
interfering proteins to the antigen adsorption. The 
selectivity tests were conducted by measuring the 
amperometric response of the pAb-based 
immunosensor against a 1000-fold concentration of 
each test protein compared to that given by ca. 100 pg 
(1 µL, 94 ng/mL) of the antigen. The addition of 100 
ng (1 µL, 100 µg/mL) of α-LA showed no effect (Fig. 
6a) on the biosensor response, whereas the addition of 
94 pg of human IgG induced an approximately 25% 
increase in DPV current; similar results were obtained 
with BSA and OVA (Fig. S5) [42]. Based on the 
results (summarised in Fig. 6b.), we concluded that the 
pAb-immunosensor is highly selective for human IgG 
protein.  
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Fig. 6. Selectivity and specificity of the pAb-based 
immunosensor for human IgG, as tested against possible 
interfering proteins: (a) DPV current response of the sensor to α-
LA protein (see ESI for the analogous tests with BSA and OVA); 
(b) Histograms summarising the sensors’ relative selectivity for 
human IgG, BSA, α-LA and OVA; (c) DPV current response to 
antigen and to a mixture of antigen and a 1000-fold excess of 
OVA protein; and (d) amperometric response of the 
immunosensor to human IgG and BSA, human IgG and α-LA, 
and human IgG and OVA. 
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 We performed additional experiments to 
demonstrate the specificity of the pAb-based 
immunosensor for human IgG. The results are 
summarised in the histogram of Fig. 6d. To evaluate 
its specificity for the antigen over OVA, its responses 
to the antigen alone and to the antigen in presence of 
OVA were measured and then compared. The 
electrochemical signals were very similar in presence 
or absence of OVA (difference: 1.1%), demonstrating 
the very high specificity to human IgG (Fig. 6b). Each 
measurement was run in triplicate to ensure 
reproducibility (the analogous results from BSA and 
α-LA are given in Fig. S6) [37]. 
4. Conclusions 
 We have designed and fabricated two 
immunosensors based on ferrocene-modified gold 
nanoparticles functionalised with either monoclonal 
(mAb) or polyclonal (pAb) anti-human IgG 
antibodies. We have demonstrated that the 
amperometric response of these immunosensors 
depends on the antibodies used. In both sensors, the 
antigen binding leads to a change in the ferrocene 
oxidation current. However, and quite surprisingly, in 
the mAb-based sensor, immunosensing leads to a 
decrease in current, whereas in the pAb-based sensor, 
it leads to an increase in current (Figure 1). The former 
can be explained by the formation of a protein layer 
that inhibits electron transfer from the ferrocene 
moieties to the electrode surface, whereas the latter 
can be explained by agglomeration of the AuNPs, 
which enhanced the electron transfer. Further 
investigations proved that the latter response stems 
from aggregation of the NPs. The pAb-based sensor 
performed better, exhibiting greater sensitivity (2.28 
10-3 µA·mL/ng) and a higher LoD (0.87 ng/mL). 
Given their wide detection range, these label-free, fast 
and versatile sensors can be adapted to many different 
analytes, making them useful for diagnostic, 
environmental and safety applications.  
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